These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8095115)
1. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection. Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115 [No Abstract] [Full Text] [Related]
2. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Mennander A; Räisänen A; Paavonen T; Häyry P Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476 [TBL] [Abstract][Full Text] [Related]
4. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis. Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189 [TBL] [Abstract][Full Text] [Related]
5. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat. MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130 [No Abstract] [Full Text] [Related]
6. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433 [No Abstract] [Full Text] [Related]
7. Impact of ischemia time on chronic vascular rejection in the rat--effects of angiopeptin. Wanders A; Akyürek ML; Waltenberger J; Stafberg C; Larsson E; Zhiping R; Funa K; Fellström B Transplant Proc; 1993 Apr; 25(2):2098-9. PubMed ID: 8097069 [No Abstract] [Full Text] [Related]
8. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471 [TBL] [Abstract][Full Text] [Related]
9. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Mennander A; Paavonen T; Häyry P Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503 [TBL] [Abstract][Full Text] [Related]
10. Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit. Foegh ML; Asotra S; Conte JV; Howell M; Kagan E; Verma K; Ramwell PW J Vasc Surg; 1994 Jun; 19(6):1084-91. PubMed ID: 7911163 [TBL] [Abstract][Full Text] [Related]
11. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619. Zhao Y; Foegh ML Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208 [TBL] [Abstract][Full Text] [Related]
12. Accelerated cardiac transplant atherosclerosis/chronic rejection in rabbits: inhibition by angiopeptin. Foegh ML Transplant Proc; 1993 Apr; 25(2):2095-7. PubMed ID: 8097068 [No Abstract] [Full Text] [Related]
13. Experimental transplant arteriosclerosis: inhibition by angiopeptin and low molecular weight heparin derivatives. Akyürek ML; Larsson E; Funa K; Wanders A; Kaijser M; Fellström BC Transplant Proc; 1995 Dec; 27(6):3555-6. PubMed ID: 8540099 [No Abstract] [Full Text] [Related]
14. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Lundergan C; Foegh ML; Vargas R; Eufemio M; Bormes GW; Kot PA; Ramwell PW Atherosclerosis; 1989 Nov; 80(1):49-55. PubMed ID: 2574977 [TBL] [Abstract][Full Text] [Related]
15. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis. Mennander A; Tiisala S; Paavonen T; Halttunen J; Häyry P Transpl Int; 1991 Sep; 4(3):173-9. PubMed ID: 1958283 [TBL] [Abstract][Full Text] [Related]
16. Effect of immunosuppression on chronic rejection in the rat aortic allograft model. Belitsky P; Gulanikar A; He G; Gupta R Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272 [No Abstract] [Full Text] [Related]